MapLight Therapeutics, Inc.
MPLT
$16.14
$0.140.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.62% | 22.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.25% | 7.82% | |||
| Operating Income | -30.25% | -7.82% | |||
| Income Before Tax | -33.60% | -11.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -33.60% | -11.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.60% | -11.02% | |||
| EBIT | -30.25% | -7.82% | |||
| EBITDA | -30.60% | -8.00% | |||
| EPS Basic | -33.35% | -10.65% | |||
| Normalized Basic EPS | -34.22% | -11.81% | |||
| EPS Diluted | -33.35% | -10.65% | |||
| Normalized Diluted EPS | -34.22% | -11.81% | |||
| Average Basic Shares Outstanding | 0.20% | 0.33% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||